| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | pyruvate kinase activity | 2.74e-05 | 2 | 105 | 2 | GO:0004743 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor | 1.18e-04 | 48 | 105 | 4 | GO:0016620 | |
| GeneOntologyMolecularFunction | BAT3 complex binding | 1.63e-04 | 4 | 105 | 2 | GO:1904288 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the aldehyde or oxo group of donors | 2.15e-04 | 56 | 105 | 4 | GO:0016903 | |
| GeneOntologyMolecularFunction | ligase activity | 3.17e-04 | 174 | 105 | 6 | GO:0016874 | |
| GeneOntologyBiologicalProcess | translesion synthesis | 9.03e-06 | 26 | 106 | 4 | GO:0019985 | |
| GeneOntologyCellularComponent | insulin-responsive compartment | 1.97e-05 | 11 | 105 | 3 | GO:0032593 | |
| GeneOntologyCellularComponent | pyruvate kinase complex | 2.50e-05 | 2 | 105 | 2 | GO:1902912 | |
| GeneOntologyCellularComponent | CKM complex | 2.47e-04 | 5 | 105 | 2 | GO:1990508 | |
| Domain | - | 3.07e-05 | 2 | 104 | 2 | 3.40.1380.20 | |
| Domain | PYRUVATE_KINASE | 3.07e-05 | 2 | 104 | 2 | PS00110 | |
| Domain | Pyrv_Knase_insert_dom | 3.07e-05 | 2 | 104 | 2 | IPR015806 | |
| Domain | PK | 3.07e-05 | 2 | 104 | 2 | PF00224 | |
| Domain | PK_C | 3.07e-05 | 2 | 104 | 2 | PF02887 | |
| Domain | - | 3.07e-05 | 2 | 104 | 2 | 2.40.33.10 | |
| Domain | Pyrv_Knase_AS | 3.07e-05 | 2 | 104 | 2 | IPR018209 | |
| Domain | Pyrv_Knase_brl | 3.07e-05 | 2 | 104 | 2 | IPR015793 | |
| Domain | Pyrv_Knase_a/b | 3.07e-05 | 2 | 104 | 2 | IPR015794 | |
| Domain | Pyrv_Knase_C | 3.07e-05 | 2 | 104 | 2 | IPR015795 | |
| Domain | Pyr_Knase | 9.18e-05 | 3 | 104 | 2 | IPR001697 | |
| Domain | Pyrv/PenolPyrv_Kinase-like_dom | 9.18e-05 | 3 | 104 | 2 | IPR015813 | |
| Domain | - | 9.18e-05 | 3 | 104 | 2 | 3.20.20.60 | |
| Domain | Pyrv_Knase-like_insert_dom | 3.04e-04 | 5 | 104 | 2 | IPR011037 | |
| Domain | RIH_assoc-dom | 4.54e-04 | 6 | 104 | 2 | IPR013662 | |
| Domain | GATASE_TYPE_1 | 4.54e-04 | 6 | 104 | 2 | PS51273 | |
| Domain | Ins145_P3_rec | 4.54e-04 | 6 | 104 | 2 | PF08709 | |
| Domain | GATASE | 4.54e-04 | 6 | 104 | 2 | IPR017926 | |
| Domain | RIH_assoc | 4.54e-04 | 6 | 104 | 2 | PF08454 | |
| Domain | RIH_dom | 4.54e-04 | 6 | 104 | 2 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 4.54e-04 | 6 | 104 | 2 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 4.54e-04 | 6 | 104 | 2 | IPR015925 | |
| Domain | - | 4.54e-04 | 6 | 104 | 2 | 1.25.10.30 | |
| Domain | RYDR_ITPR | 4.54e-04 | 6 | 104 | 2 | PF01365 | |
| Domain | PH-BEACH_dom | 8.41e-04 | 8 | 104 | 2 | IPR023362 | |
| Domain | - | 8.41e-04 | 8 | 104 | 2 | 2.30.29.40 | |
| Domain | PH_BEACH | 8.41e-04 | 8 | 104 | 2 | PS51783 | |
| Domain | BEACH | 1.08e-03 | 9 | 104 | 2 | PS50197 | |
| Domain | Beach | 1.08e-03 | 9 | 104 | 2 | PF02138 | |
| Domain | - | 1.08e-03 | 9 | 104 | 2 | 1.10.1540.10 | |
| Domain | Beach | 1.08e-03 | 9 | 104 | 2 | SM01026 | |
| Domain | BEACH_dom | 1.08e-03 | 9 | 104 | 2 | IPR000409 | |
| Domain | MIR | 1.34e-03 | 10 | 104 | 2 | PF02815 | |
| Domain | - | 1.34e-03 | 10 | 104 | 2 | 3.40.50.880 | |
| Domain | MIR_motif | 1.34e-03 | 10 | 104 | 2 | IPR016093 | |
| Domain | MIR | 1.34e-03 | 10 | 104 | 2 | PS50919 | |
| Domain | MIR | 1.34e-03 | 10 | 104 | 2 | SM00472 | |
| Domain | Class_I_gatase-like | 1.95e-03 | 12 | 104 | 2 | IPR029062 | |
| Domain | Beta/gamma_crystallin | 3.08e-03 | 15 | 104 | 2 | IPR001064 | |
| Domain | CRYSTALLIN_BETA_GAMMA | 3.08e-03 | 15 | 104 | 2 | PS50915 | |
| Domain | Crystall | 3.08e-03 | 15 | 104 | 2 | PF00030 | |
| Domain | XTALbg | 3.08e-03 | 15 | 104 | 2 | SM00247 | |
| Domain | G_crystallin-rel | 4.43e-03 | 18 | 104 | 2 | IPR011024 | |
| Pathway | REACTOME_TRANSLESION_SYNTHESIS_BY_Y_FAMILY_DNA_POLYMERASES_BYPASSES_LESIONS_ON_DNA_TEMPLATE | 9.02e-05 | 39 | 86 | 4 | M26897 | |
| Pathway | REACTOME_TRANSLESION_SYNTHESIS_BY_Y_FAMILY_DNA_POLYMERASES_BYPASSES_LESIONS_ON_DNA_TEMPLATE | 9.02e-05 | 39 | 86 | 4 | MM14475 | |
| Pathway | KEGG_PYRUVATE_METABOLISM | 9.98e-05 | 40 | 86 | 4 | M7934 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | NES REXO4 CASP14 MYO5A ACLY IARS1 POLD1 SENP3 PFAS YBX3 IDH3B PTBP1 GTF3C4 FAM83H DNAJA3 ACSL3 UBN1 ABCE1 RTCA PKM RACGAP1 TIMM44 YME1L1 ALDH7A1 VCP | 4.41e-13 | 1353 | 108 | 25 | 29467282 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | REXO4 KIF27 TCOF1 ACLY IARS1 POLD1 CHAF1A PFAS YBX3 IDH3B PTBP1 DNAJA3 ACSL3 ABCE1 SURF4 PKM RACGAP1 DLD TIMM44 | 7.90e-08 | 1425 | 108 | 19 | 30948266 |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | TCOF1 ACLY IARS1 POLD1 CHAF1A SENP3 DVL3 PTBP1 FAM83H METAP1 DNAJA3 MRPL16 ABCE1 SURF4 PKLR PKM DLD TIMM44 | 1.27e-07 | 1318 | 108 | 18 | 30463901 |
| Pubmed | MYO5A TCOF1 USE1 POLD1 MPDZ PFAS ITPR1 DNAJA3 ACSL3 CASKIN2 SURF4 DLD AKT2 TYW1 CRYBG3 TIMM44 YME1L1 FAM177A1 VCP | 1.53e-07 | 1487 | 108 | 19 | 33957083 | |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | ACLY IARS1 POLD1 PFAS YBX3 IDH3B PTBP1 GTF3C4 DNAJA3 ACSL3 CTPS2 ABCE1 PKM DLD TIMM44 YME1L1 VCP | 3.41e-07 | 1257 | 108 | 17 | 37317656 |
| Pubmed | 4.16e-07 | 217 | 108 | 8 | 30619736 | ||
| Pubmed | MYO5A IARS1 DVL3 PTBP1 ITPR1 DNAJA3 ACSL3 ABCE1 SV2A PKM DLD AKT2 CRYBG3 TIMM44 FAM177A1 VCP | 4.76e-07 | 1139 | 108 | 16 | 36417873 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | NES CASP14 MYO5A TCOF1 ACLY IARS1 IDH3B PTBP1 FAM83H KIAA1671 ACSL3 SURF4 PKM RACGAP1 VCP | 6.67e-07 | 1024 | 108 | 15 | 24711643 |
| Pubmed | Identification of Zika Virus and Dengue Virus Dependency Factors using Functional Genomics. | 8.36e-07 | 422 | 108 | 10 | 27342126 | |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | LRRC8E USP13 CASP14 TCOF1 USE1 IARS1 GOLM2 MCAM PTBP1 GTF3C4 ACSL3 SV2A SURF4 PKM LRP1 VCP | 9.75e-07 | 1203 | 108 | 16 | 29180619 |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | UBA5 NES CASP14 TCOF1 IARS1 DVL3 PFAS METAP1 ACSL3 ABCE1 RTCA CST3 PKM LRP1 DLD ALDH7A1 VCP | 1.08e-06 | 1367 | 108 | 17 | 32687490 |
| Pubmed | 1.58e-06 | 114 | 108 | 6 | 28245920 | ||
| Pubmed | CDK8 TCOF1 POLD1 CHAF1A IDH3B EZH1 FAM83H KIAA1671 DNAJA3 SV2A LRP1 ZFHX3 CRYBG3 YME1L1 VCP | 1.93e-06 | 1116 | 108 | 15 | 31753913 | |
| Pubmed | ATG5 is required for B cell polarization and presentation of particulate antigens. | CWF19L2 POLD1 PTBP1 ITPR1 METAP1 DNAJA3 MRPL16 ABCE1 RTCA PKM YME1L1 VCP | 1.96e-06 | 701 | 108 | 12 | 30196744 |
| Pubmed | 1.96e-06 | 360 | 108 | 9 | 33111431 | ||
| Pubmed | Quantitative high-confidence human mitochondrial proteome and its dynamics in cellular context. | ATPSCKMT TRIAP1 DHRS4L2 IDH3B ARMCX2 DNAJA3 AGXT2 DHRS4 CTPS2 MRPL16 RACGAP1 DLD TIMM44 YME1L1 ALDH7A1 | 2.40e-06 | 1136 | 108 | 15 | 34800366 |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | USP13 CASP14 TCOF1 IARS1 USP43 MPDZ PFAS CTPS2 ABCE1 RTCA PKLR LRP1 MTCL1 VCP | 2.91e-06 | 1005 | 108 | 14 | 19615732 |
| Pubmed | 3.18e-06 | 382 | 108 | 9 | 29222160 | ||
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | RPGRIP1L USE1 TRIAP1 DYNC2I1 YBX3 IDH3B ARMCX2 ITPR1 KIAA1671 DNAJA3 ACSL3 MRPL16 ABCE1 CRYBG3 TIMM44 YME1L1 VCP | 3.64e-06 | 1496 | 108 | 17 | 32877691 |
| Pubmed | CASP14 MYO5A TCOF1 YBX3 EZH1 GTF3C4 KIAA1671 DNAJA3 LRP1 AKT2 YME1L1 | 4.73e-06 | 634 | 108 | 11 | 34591612 | |
| Pubmed | 4.91e-06 | 403 | 108 | 9 | 30562941 | ||
| Pubmed | 6.21e-06 | 312 | 108 | 8 | 37120454 | ||
| Pubmed | 6.46e-06 | 417 | 108 | 9 | 36537216 | ||
| Pubmed | LRRC8E UBA5 SEMA4F USP13 REXO4 USE1 SENP3 SV2A SURF4 POLI RACGAP1 ULK1 | 6.95e-06 | 794 | 108 | 12 | 11076863 | |
| Pubmed | CDK8 TCOF1 ACLY IARS1 POLD1 DVL3 PFAS IDH3B PTBP1 FAM83H ABCE1 PKM RACGAP1 DLD VCP | 7.39e-06 | 1247 | 108 | 15 | 27684187 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 11960989 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 35181333 | ||
| Pubmed | Regulatory functions of the Mediator kinases CDK8 and CDK19. | 9.55e-06 | 2 | 108 | 2 | 30585107 | |
| Pubmed | Structural basis for tumor pyruvate kinase M2 allosteric regulation and catalysis. | 9.55e-06 | 2 | 108 | 2 | 15996096 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 37735673 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 31044597 | ||
| Pubmed | Alternative transcription initiation and splicing variants of the DHRS4 gene cluster. | 9.55e-06 | 2 | 108 | 2 | 18754758 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 37947604 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 32560467 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 27258849 | ||
| Pubmed | Abnormal PTBP1 Expression Sustains the Disease Progression of Multiple Myeloma. | 9.55e-06 | 2 | 108 | 2 | 32655719 | |
| Pubmed | [Mechanisms of transcriptional regulation upon protein phosphorylation by mediator complexes]. | 9.55e-06 | 2 | 108 | 2 | 20408451 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 15473316 | ||
| Pubmed | Mediator kinase inhibition further activates super-enhancer-associated genes in AML. | 9.55e-06 | 2 | 108 | 2 | 26416749 | |
| Pubmed | CDK8/19 Mediator kinases potentiate induction of transcription by NFκB. | 9.55e-06 | 2 | 108 | 2 | 28855340 | |
| Pubmed | The molecular motor Myosin Va interacts with the cilia-centrosomal protein RPGRIP1L. | 9.55e-06 | 2 | 108 | 2 | 28266547 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 26234680 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 27678455 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 36006697 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 27134178 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 17230527 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 37378433 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 28347241 | ||
| Pubmed | Identification of target genes for the CDK subunits of the Mediator complex. | 9.55e-06 | 2 | 108 | 2 | 22117896 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | TCOF1 ACLY POLD1 IFT172 DPYSL5 MPDZ PFAS ACSL3 ABCE1 LRP1 DLD YME1L1 VCP | 1.07e-05 | 974 | 108 | 13 | 28675297 |
| Pubmed | USP11 mediates repair of DNA-protein cross-links by deubiquitinating SPRTN metalloprotease. | 1.10e-05 | 565 | 108 | 10 | 33567341 | |
| Pubmed | 1.11e-05 | 242 | 108 | 7 | 34011540 | ||
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | NES MYO5A TCOF1 ACLY IARS1 POLD1 MPDZ PFAS YBX3 PTBP1 DNAJA3 PKM ALDH7A1 VCP | 1.33e-05 | 1149 | 108 | 14 | 35446349 |
| Pubmed | TCOF1 TRIAP1 ACLY MCAM IDH3B ARMCX2 PKM LRP1 DLD TIMM44 ALDH7A1 VCP | 1.52e-05 | 859 | 108 | 12 | 31536960 | |
| Pubmed | LRRC8E UBA5 SEMA4F USP13 REXO4 USE1 SENP3 SV2A SURF4 POLI RACGAP1 | 1.55e-05 | 720 | 108 | 11 | 16381901 | |
| Pubmed | LRRC8E UBA5 SEMA4F USP13 REXO4 USE1 SENP3 SV2A SURF4 POLI RACGAP1 | 1.59e-05 | 722 | 108 | 11 | 15489336 | |
| Pubmed | TCOF1 ACLY IARS1 MPDZ YBX3 PTBP1 GTF3C4 DNAJA3 CTPS2 MRPL16 PKM DLD YME1L1 ALDH7A1 VCP | 1.65e-05 | 1335 | 108 | 15 | 29229926 | |
| Pubmed | SEMA4F NES RPGRIP1L CHAF1A DYNC2I1 MPDZ GTF3C4 RACGAP1 AKT2 TYW1 TIMM44 | 1.83e-05 | 733 | 108 | 11 | 34672954 | |
| Pubmed | A mitochondrial protein compendium elucidates complex I disease biology. | TRIAP1 ACLY DHRS4L2 IDH3B DNAJA3 AGXT2 DHRS4 CTPS2 MRPL16 DLD TIMM44 YME1L1 ALDH7A1 | 2.27e-05 | 1047 | 108 | 13 | 18614015 |
| Pubmed | MET Inhibitors Promote Liver Tumor Evasion of the Immune Response by Stabilizing PDL1. | 2.33e-05 | 182 | 108 | 6 | 30711629 | |
| Pubmed | Repression of rRNA transcription by PARIS contributes to Parkinson's disease. | 2.36e-05 | 272 | 108 | 7 | 25315684 | |
| Pubmed | NES CASP14 MYO5A ACLY MPDZ PLEKHG2 KIAA1671 MRPL16 SURF4 RACGAP1 DLD YME1L1 | 2.85e-05 | 916 | 108 | 12 | 32203420 | |
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 27892457 | ||
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 27323117 | ||
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 26002960 | ||
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 10333503 | ||
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 20525226 | ||
| Pubmed | A variation in mouse kidney pyruvate kinase activity determined by a mutant gene on chromosome 9. | 2.86e-05 | 3 | 108 | 2 | 7262549 | |
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 12680773 | ||
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 17515613 | ||
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 31391218 | ||
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 28414323 | ||
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 28151579 | ||
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 20472562 | ||
| Pubmed | FGF2 stimulates SDF-1 expression through the Erm transcription factor in Sertoli cells. | 2.86e-05 | 3 | 108 | 2 | 19301256 | |
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 35430343 | ||
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 15805117 | ||
| Pubmed | The IKKβ-USP30-ACLY Axis Controls Lipogenesis and Tumorigenesis. | 2.86e-05 | 3 | 108 | 2 | 32221968 | |
| Pubmed | 3.11e-05 | 638 | 108 | 10 | 33239621 | ||
| Pubmed | Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism. | UBA5 TCF3 REXO4 MYO5A USE1 IARS1 POLD1 GOLM2 PFAS CASKIN2 SURF4 POLI | 3.14e-05 | 925 | 108 | 12 | 28986522 |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | TCOF1 ACLY IARS1 POLD1 PFAS YBX3 IDH3B PTBP1 DNAJA3 CTPS2 SLC16A3 PKM MTCL1 TIMM44 VCP | 3.23e-05 | 1415 | 108 | 15 | 28515276 |
| Pubmed | USP13 SENP3 MPDZ PFAS ITPR1 CASKIN2 ABCE1 RACGAP1 ULK1 CRYBG3 | 3.64e-05 | 650 | 108 | 10 | 38777146 | |
| Pubmed | 3.78e-05 | 653 | 108 | 10 | 22586326 | ||
| Pubmed | AIMP2-DX2 provides therapeutic interface to control KRAS-driven tumorigenesis. | 3.94e-05 | 200 | 108 | 6 | 35546148 | |
| Pubmed | 4.30e-05 | 22 | 108 | 3 | 22705452 | ||
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | UBA5 ACLY IARS1 POLD1 PFAS YBX3 PTBP1 GTF3C4 CTPS2 ABCE1 PKM DLD IKBKB ALDH7A1 VCP | 4.44e-05 | 1455 | 108 | 15 | 22863883 |
| Pubmed | 4.77e-05 | 304 | 108 | 7 | 32235678 | ||
| Pubmed | CASP14 TCOF1 YBX3 PTBP1 GTF3C4 DNAJA3 RTCA PKM LRP1 RACGAP1 MTCL1 TIMM44 | 5.01e-05 | 971 | 108 | 12 | 33306668 | |
| Pubmed | FGF11 induced by hypoxia interacts with HIF-1α and enhances its stability. | 5.14e-05 | 128 | 108 | 5 | 28027390 | |
| Pubmed | 5.65e-05 | 425 | 108 | 8 | 21081503 | ||
| Pubmed | 5.71e-05 | 4 | 108 | 2 | 16406282 | ||
| Pubmed | 5.71e-05 | 4 | 108 | 2 | 29440396 | ||
| Pubmed | Ryanodine receptor calcium release channels: lessons from structure-function studies. | 5.71e-05 | 4 | 108 | 2 | 23413940 | |
| Pubmed | ULK1 and ULK2 Regulate Stress Granule Disassembly Through Phosphorylation and Activation of VCP/p97. | 5.71e-05 | 4 | 108 | 2 | 30979586 | |
| Pubmed | 5.71e-05 | 4 | 108 | 2 | 9607712 | ||
| Pubmed | 5.71e-05 | 4 | 108 | 2 | 23615909 | ||
| Pubmed | Molecular and functional evolution of human DHRS2 and DHRS4 duplicated genes. | 5.71e-05 | 4 | 108 | 2 | 23036705 | |
| Pubmed | Cdk8 is required for establishment of H3K27me3 and gene repression by Xist and mouse development. | 5.71e-05 | 4 | 108 | 2 | 32439758 | |
| Pubmed | 5.71e-05 | 4 | 108 | 2 | 21610068 | ||
| Pubmed | 5.71e-05 | 4 | 108 | 2 | 19240031 | ||
| Interaction | ATG16L1 interactions | CWF19L2 USP13 RPGRIP1L MYO5A POLD1 PFAS PTBP1 ITPR1 METAP1 DNAJA3 MRPL16 ABCE1 SURF4 RTCA PKM MTCL1 ULK1 CRYBG3 YME1L1 VCP | 2.34e-06 | 1161 | 106 | 20 | int:ATG16L1 |
| Interaction | EGLN3 interactions | TCF3 POLD1 IFT172 DVL3 DYNC2I1 PFAS IDH3B GTF3C4 FAM83H KIAA1671 DNAJA3 ACSL3 ABCE1 PKM RACGAP1 MTCL1 IKBKB TIMM44 YME1L1 NOTCH3 VCP | 3.29e-06 | 1296 | 106 | 21 | int:EGLN3 |
| Interaction | GSK3B interactions | CASP14 ACLY GOLM2 MPDZ PFAS YBX3 PTBP1 KIAA1671 ACSL3 ABCE1 PKM AKT2 MTCL1 CRYBG3 NOTCH3 VCP | 1.19e-05 | 868 | 106 | 16 | int:GSK3B |
| Interaction | HIF1A interactions | CDK8 NES NBEAL1 SENP3 IDH3B PTBP1 DNAJA3 PKM RACGAP1 IKBKB VCP | 2.09e-05 | 441 | 106 | 11 | int:HIF1A |
| Interaction | NR2C2 interactions | TCOF1 ACLY IARS1 POLD1 CHAF1A SENP3 DVL3 PTBP1 FAM83H METAP1 DNAJA3 UBN1 MRPL16 ABCE1 SURF4 PKLR PKM DLD IKBKB TIMM44 | 3.78e-05 | 1403 | 106 | 20 | int:NR2C2 |
| GeneFamily | Beta-gamma crystallin domain containing | 5.08e-05 | 3 | 75 | 2 | 1360 | |
| GeneFamily | WD repeat domain containing|BEACH domain containing | 6.00e-04 | 9 | 75 | 2 | 1230 | |
| Coexpression | BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_INFECTION_UP | 1.54e-06 | 137 | 107 | 7 | M34024 | |
| Coexpression | GSE15330_GRANULOCYTE_MONOCYTE_PROGENITOR_VS_PRO_BCELL_UP | 1.64e-06 | 199 | 107 | 8 | M7041 | |
| Coexpression | BLUM_RESPONSE_TO_SALIRASIB_UP | 7.64e-06 | 245 | 107 | 8 | M7300 | |
| Coexpression | DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN | 1.81e-05 | 276 | 107 | 8 | M3063 | |
| Coexpression | GSE3982_MAC_VS_BASOPHIL_UP | 1.86e-05 | 200 | 107 | 7 | M5496 | |
| ToppCell | COVID-19-Heart-Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 3.36e-07 | 184 | 108 | 7 | 21790cdfa3b4036ad413fd44b94e31563116f25f | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.61e-07 | 186 | 108 | 7 | 4780af76237d7af2abbe2d8d5530cdf53e3ed0b7 | |
| ToppCell | droplet-Marrow-BM-1m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.97e-07 | 195 | 108 | 7 | 637b06ef3967b03f7165d102d316e8b7161a817d | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.71e-06 | 170 | 108 | 6 | 5570c0e825bca77613bf0ebde620cf744fa1cb84 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.10e-06 | 173 | 108 | 6 | 2415b6ff49f334da570577d4e93484d024a3dbd5 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.10e-06 | 173 | 108 | 6 | 2acd0693a2dfe04e3c1b2125ea63efe92d13150b | |
| ToppCell | Pericytes-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 5.31e-06 | 181 | 108 | 6 | 35c470988a93381eefa300831aabb813fa1b90bd | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.81e-06 | 189 | 108 | 6 | 975e7aa3b862a8b07c2ab8426a14f5cc54998aca | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.01e-06 | 190 | 108 | 6 | 951e067d14412db67dc3babcdf61e41717d7b429 | |
| ToppCell | MatrixFB-Fibroblast-D_(Pericyte)|MatrixFB / shred on cell class and cell subclass (v4) | 7.45e-06 | 192 | 108 | 6 | 630444302511f511ec6976bc045a3b4b9d8d4547 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.90e-06 | 194 | 108 | 6 | 68d15917ae222cba0ad9e716d29eebb6c5f00f69 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.38e-06 | 196 | 108 | 6 | 184104cbea0461dd2757668ab9755948ac7b585a | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Mesenchymal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.38e-06 | 196 | 108 | 6 | bebb20dc210576101c317011e3afb59798f5d255 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.38e-06 | 196 | 108 | 6 | 8114e98923096c54b6834f21550c3061bab6773d | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Fezf2-Excitatory_Neuron.Slc17a7-Slc17a8.Fezf2-Slc17a8_(Layer_5,_Retrosplenial_cortex_(RSG)_and_Subiculum,_Tshz2+)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.85e-05 | 72 | 108 | 4 | e3f4d1df43cc41b0424f27485a00ddca9e905f95 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.47e-05 | 152 | 108 | 5 | 0cb5f4dfae04e3f4eba502bbf229007d5fa3884d | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.47e-05 | 152 | 108 | 5 | ba89ffb5a8bb33c188f854f54b39123b6d73496a | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-24m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.43e-05 | 167 | 108 | 5 | 7f3224af9b30082b927a822b91f96e0c88151b4e | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-24m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.43e-05 | 167 | 108 | 5 | a21a2b301d0a3d7a41e605f7a3c37548962a331d | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-24m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.43e-05 | 167 | 108 | 5 | 0e746483773bde6582874a33591ab2a578d724eb | |
| ToppCell | 356C-Fibroblasts-Fibroblast-H-|356C / Donor, Lineage, Cell class and subclass (all cells) | 5.59e-05 | 168 | 108 | 5 | b5d74500bdac0d680ce7eb7afa0b867b8d85e6a4 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-H|356C / Donor, Lineage, Cell class and subclass (all cells) | 5.59e-05 | 168 | 108 | 5 | 838ce47d4958ba12047882f97925eddd02f081c7 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-24m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.91e-05 | 170 | 108 | 5 | b4f2c05db2c2591561fd42febc72eed3b5e8f9fb | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.60e-05 | 174 | 108 | 5 | 778e0317c0c63fa4efd74114feb760975b819d92 | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-pDCs|Myeloid_cells / Location, Cell class and cell subclass | 6.60e-05 | 174 | 108 | 5 | 2274648b80dd74f3c948a779bba3391095964c34 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_G2M|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.78e-05 | 175 | 108 | 5 | fa16c6ba08dc0cc22e8cf049db0577811d080df6 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.78e-05 | 175 | 108 | 5 | 316f2ea930437bf1243b1c0f45e6bd864112c6f2 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.78e-05 | 175 | 108 | 5 | a9f08e1e4c2997dcdd3e5d92daac480da19100b8 | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-pDCs|normal_Lymph_Node / Location, Cell class and cell subclass | 6.96e-05 | 176 | 108 | 5 | 476794ef75ce5ab732d78cfeb4944e2f841e3e92 | |
| ToppCell | COVID-19-kidney-vSMC/Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.54e-05 | 179 | 108 | 5 | 111b1084f73306bdeffaaf240e7dbb4f5bf33de1 | |
| ToppCell | 3'-Adult-LargeIntestine-Epithelial-Tuft-related-Tuft|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.54e-05 | 179 | 108 | 5 | 906555ce2ca264a0215b120c7ff7c9b411de6a34 | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Aerocyte_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.95e-05 | 181 | 108 | 5 | cd81bc307e2bc42c1e9b24d5645ab65fa18c6133 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Mesenchymal-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.95e-05 | 181 | 108 | 5 | 709e9c7a60d5f98635b99895ce30bb87a9f7376d | |
| ToppCell | Pericytes-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 8.37e-05 | 183 | 108 | 5 | d04deef7cd4e1738227a6593b84874ce0168c773 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.81e-05 | 185 | 108 | 5 | 51dfe6ac7df8b330343b37e3bee71e5c65267189 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.81e-05 | 185 | 108 | 5 | a8c02cec3c414f3a0da9f2d6d28ce563b0030705 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.04e-05 | 186 | 108 | 5 | a95744b8649096bd7cfc3591a02841fa411085b3 | |
| ToppCell | P07-Mesenchymal-myocytic_cell-vascular_associated_smooth_muscle_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 9.50e-05 | 188 | 108 | 5 | 6ec22b79b19d57ea187f312907819dc2d01f3efe | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.74e-05 | 189 | 108 | 5 | de51fbd6fdb24fc4549393cf41a020005444b2aa | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 9.74e-05 | 189 | 108 | 5 | 6b3e88751b95fc2173f2c3d5061ed632d0c5f01c | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-kidney_mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.99e-05 | 190 | 108 | 5 | 1803b1e7c36285f9eaabc3c6e9a9752c5908db3d | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.99e-05 | 190 | 108 | 5 | 10b02c62e72bfea9767e3e751011436925da823e | |
| ToppCell | E15.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 9.99e-05 | 190 | 108 | 5 | 84fbd5664ec886120963d4f50dfa1fd1851d36c1 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.02e-04 | 191 | 108 | 5 | 08042952431ca1a6fd7dfc13f36eb28643979598 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.02e-04 | 191 | 108 | 5 | 7853ac7dff649150e6ff27cd4c8cf7c1fc034ed4 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-04 | 191 | 108 | 5 | 04c4d454b57e29a8d1dcdeb4678ce71bdc29b77b | |
| ToppCell | droplet-Pancreas-Endocrine|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-04 | 192 | 108 | 5 | 0dfd1e9896c34aee0f842f8de5d0e3af62a15f68 | |
| ToppCell | (1)_Control_(PBS)-(3)_LEPR+_perivascular_cells|(1)_Control_(PBS) / Stress and Cell class | 1.05e-04 | 192 | 108 | 5 | 40f380f5f0bed63a7404be050838ebd01ef08987 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.07e-04 | 193 | 108 | 5 | 000b9e6a819b94ea2e6e9173daf97ba9ac2b6cc6 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.07e-04 | 193 | 108 | 5 | 88916d9a7d831eb52848599917c04238f8f9812b | |
| ToppCell | facs-Lung-18m-Endothelial-capillary_endothelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.07e-04 | 193 | 108 | 5 | ee4b31d9c92f8fd0d3ddb5e723b82300fcb459d1 | |
| ToppCell | facs-Lung-18m-Endothelial-capillary_endothelial-capillary_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.07e-04 | 193 | 108 | 5 | 7401e276b644b254c692160d0e7417ec28d50aa4 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.07e-04 | 193 | 108 | 5 | 7386fadc13a437f3b0c99b5d116cd3c5f893529c | |
| ToppCell | droplet-Pancreas-Endocrine-21m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-04 | 194 | 108 | 5 | 3a3ecedcdc7691cf21775818b598208fcb980c29 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_neuro-secretory|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.10e-04 | 194 | 108 | 5 | d024cd75a97f048257e49cee9190fb2e79202ee2 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.10e-04 | 194 | 108 | 5 | 6a4e7f1bf67bad94cd8c472e7c66798b0c25ba01 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-04 | 194 | 108 | 5 | 0b023de48ed8a550d169bbe954881eb04bf4f981 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.10e-04 | 194 | 108 | 5 | 67f5e2f05a8de2213ab80d5ea16fdee121684633 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.13e-04 | 195 | 108 | 5 | 481989d2e5bd2582da3d86b0155c4d6615317067 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.13e-04 | 195 | 108 | 5 | 6108a27523d1b93a7fbe35cb95704a5ad9071e3c | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.13e-04 | 195 | 108 | 5 | 4a5d2f62aad5817d077177bf8b4ff0e46d3b8d97 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-AC-like-AC-like-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.13e-04 | 195 | 108 | 5 | 32ec72103faccc9e37c0ecedff1998e7df6a19f6 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-04 | 195 | 108 | 5 | a1478021a3ed0e779716393124ca2a7770c433b7 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.13e-04 | 195 | 108 | 5 | 7a32a8535c29b819dacba901d0658280a2631c94 | |
| ToppCell | Fibroblasts-Pericytes|Fibroblasts / lung cells shred on cell class, cell subclass, sample id | 1.13e-04 | 195 | 108 | 5 | c2ebc0b33bda9b35b9ef26d69e5d2c6acfdb6ff1 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_myocytic|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.16e-04 | 196 | 108 | 5 | acbb493dbb49a33f20cf11106363f7ed51209706 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.16e-04 | 196 | 108 | 5 | 6708026bafd19c35c5c4e81911344d36a0f508cd | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.18e-04 | 197 | 108 | 5 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | ASK452-Endothelial-Endothelium|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.21e-04 | 198 | 108 | 5 | e282769f5fa1765bcce79a0ed9d761bf2e14b012 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_neuro-secretory-Neuroendocrine|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.21e-04 | 198 | 108 | 5 | d6812494874be0c14361ac2ac3e418b335bb8f55 | |
| ToppCell | normal_Lung-Fibroblasts-Smooth_muscle_cells|Fibroblasts / Location, Cell class and cell subclass | 1.24e-04 | 199 | 108 | 5 | d65847ceb68a560798df3f73e6f838e7c3e38a1c | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-early|World / Primary Cells by Cluster | 1.24e-04 | 199 | 108 | 5 | 549391e7a4285da1c0e366654530bcf1cd33fbae | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-early-40|World / Primary Cells by Cluster | 1.24e-04 | 199 | 108 | 5 | 23625d757173bdd35a51c7919ff4b588168d2553 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-AC-like-AC-like-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.24e-04 | 199 | 108 | 5 | a900ef002e1ae583b70be0253d8c44dae6754916 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type. | 1.27e-04 | 200 | 108 | 5 | 5ba4ed490c64b3bb738e7729669f893fa73aa56f | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.27e-04 | 200 | 108 | 5 | 410b1a31de21c57d87ca2104f61cf4a7d4dd2f30 | |
| ToppCell | mild-Myeloid-CD14_Monocytes_1|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.27e-04 | 200 | 108 | 5 | 3874c1f078cb8789be2e2275a202357c711b1be3 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.27e-04 | 200 | 108 | 5 | 74e74123ea7bf38d337a3a0248a6a51437c6ab42 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Macroglial-Glia_progenitor_cell|2m / Sample Type, Dataset, Time_group, and Cell type. | 1.27e-04 | 200 | 108 | 5 | fc9e2094f4d22412e3dd79e79649a6d46d62caec | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c10-MKI67-GZMK|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.28e-04 | 145 | 108 | 4 | 34fc6da04d4fe0817e37cdcd844fe2a6e53a4796 | |
| ToppCell | 10x5'-bone_marrow-Myeloid_Monocytic-Cycling_mono|bone_marrow / Manually curated celltypes from each tissue | 4.62e-04 | 148 | 108 | 4 | de35eeefad0e27a0d127e2e4bedead2bddb75152 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-chondrocyte-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.24e-04 | 153 | 108 | 4 | 65641cc82883716dba0fefb749a30174a63f4da5 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Myocytic|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.63e-04 | 156 | 108 | 4 | 6365b69ede98bc866e996bc52736b00401aacf6f | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-Treg-Treg_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.63e-04 | 156 | 108 | 4 | 84f01419d8c116714e8c8c857c4d153a755b7867 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_prolif|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.63e-04 | 156 | 108 | 4 | 895927228c93cd090303984c5be6ebfb59ed6f3a | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-Treg-Treg_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.63e-04 | 156 | 108 | 4 | 2285be9746d0d0f62a488b9c64fa67a834758dd7 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Fibroblasts|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.77e-04 | 157 | 108 | 4 | f086753b51860e23f1275bd75e8802d2a7d7b70a | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-Myofibro_2|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 5.77e-04 | 157 | 108 | 4 | b9d04ee417c0d8ea0801d10f1c54e138587009fd | |
| ToppCell | frontal_cortex-Non-neuronal-smooth_muscle_cell|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.91e-04 | 158 | 108 | 4 | 08806240228c5b780f5aef92ce2c278ae4d797cc | |
| ToppCell | frontal_cortex-Non-neuronal-smooth_muscle_cell-SMC-SMC_Acta2|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.91e-04 | 158 | 108 | 4 | 496b6988f7b3439968351840ae22f56ffa1643f1 | |
| ToppCell | frontal_cortex-Non-neuronal-smooth_muscle_cell-SMC|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.91e-04 | 158 | 108 | 4 | 5b3d30f92b619f14a7b48502170000fa5783358a | |
| ToppCell | Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.91e-04 | 158 | 108 | 4 | 84c0a215dabf697ada036c2b9592d0c61b5077de | |
| ToppCell | Control-Endothelial_cells-Inflamed_endothelial_cells|Control / group, cell type (main and fine annotations) | 6.19e-04 | 160 | 108 | 4 | 958256e3d3836160763b82bb48f794087918d935 | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1.5|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 6.19e-04 | 160 | 108 | 4 | 8bb873704895c3b35bba8af78fedbabf7df42e71 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal--glomerular_mesenchymal_cell-Renin-positive_Juxtaglomerular_Granular_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.49e-04 | 162 | 108 | 4 | c7114e24cb5525abb9780ca3d35dbcc4eabd4b64 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal--glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.49e-04 | 162 | 108 | 4 | f1851a173d3bcca2981d934161ec85d1cc0af5a2 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.49e-04 | 162 | 108 | 4 | 5d902bb31e691aea9749617cc88303c2448f24b8 | |
| ToppCell | LPS-IL1RA-Unknown-Endothelial-Monocytes-Macrophages|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.64e-04 | 163 | 108 | 4 | 6b11a3ada8725670d0489f404c8c2175ad3904e9 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-neuron_precursor|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.64e-04 | 163 | 108 | 4 | 99cf60dc87f7ce288553091bffcd85109a02bd8f | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-neuron_precursor-Neuroblast|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.64e-04 | 163 | 108 | 4 | 510c0af66e82c5a8cf8edd0547dae4018a87dbbf | |
| Drug | Pyruvic acid | 4.45e-07 | 14 | 107 | 4 | DB00119 | |
| Drug | AC1N02M5 | 8.30e-06 | 9 | 107 | 3 | CID003956233 | |
| Drug | 1,3-butanedione | 2.15e-05 | 12 | 107 | 3 | CID000022747 | |
| Drug | 2-Phosphoglycolic Acid | 2.19e-05 | 2 | 107 | 2 | DB02726 | |
| Drug | N-methyltaurine | 2.19e-05 | 2 | 107 | 2 | CID000007882 | |
| Drug | NPCMD | 2.19e-05 | 2 | 107 | 2 | CID000126341 | |
| Drug | BW A440C | 2.19e-05 | 2 | 107 | 2 | CID003086296 | |
| Drug | 3-(fluoromethyl)phosphoenolpyruvate | 2.19e-05 | 2 | 107 | 2 | CID006443899 | |
| Drug | SENP | 2.19e-05 | 2 | 107 | 2 | CID003082911 | |
| Drug | 8-BDB-TATP | 2.19e-05 | 2 | 107 | 2 | CID003082732 | |
| Drug | AC1Q6SAF | 2.19e-05 | 2 | 107 | 2 | CID000194977 | |
| Drug | Adenosine 5'-monophosphate 1-oxide | 2.19e-05 | 2 | 107 | 2 | CID000492161 | |
| Drug | adenine | 2.86e-05 | 510 | 107 | 11 | CID000000190 | |
| Drug | 0317956-0000 [391210-11-0]; Down 200; 10uM; MCF7; HT_HG-U133A | 3.26e-05 | 190 | 107 | 7 | 3966_DN | |
| Drug | Norethindrone [68-22-4]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 3.84e-05 | 195 | 107 | 7 | 5474_UP | |
| Drug | Dimethadione [695-53-4]; Up 200; 31uM; HL60; HT_HG-U133A | 3.97e-05 | 196 | 107 | 7 | 3029_UP | |
| Drug | Deferoxamine mesylate [138-14-7]; Down 200; 6uM; MCF7; HT_HG-U133A | 3.97e-05 | 196 | 107 | 7 | 3842_DN | |
| Drug | Artemisinin [63968-64-9]; Down 200; 14.2uM; MCF7; HT_HG-U133A | 4.23e-05 | 198 | 107 | 7 | 7007_DN | |
| Drug | oxaloacetate | 4.23e-05 | 198 | 107 | 7 | CID000000970 | |
| Drug | glutamate | NES PFAS IDH3B SLC1A7 RYR3 ITPR1 AGXT2 CTPS2 SV2A PKLR PKM FGF2 DLD YME1L1 ALDH7A1 | 4.36e-05 | 962 | 107 | 15 | CID000000611 |
| Drug | Cloethocarb | 5.92e-05 | 45 | 107 | 4 | CID000040032 | |
| Drug | diethoxyfluorescein | 6.54e-05 | 3 | 107 | 2 | CID000161373 | |
| Drug | NSC 18508 | 6.54e-05 | 3 | 107 | 2 | CID000189182 | |
| Drug | 1-thio-alpha-tocopherol | 6.54e-05 | 3 | 107 | 2 | CID000131683 | |
| Drug | 2 PEB | 6.54e-05 | 3 | 107 | 2 | CID000447809 | |
| Drug | potassium | NES MYO5A POLD1 HCN3 RGS7 SLC1A7 RYR3 ITPR1 METAP1 SV2A PKLR PKM AKT2 YME1L1 ALDH7A1 | 7.39e-05 | 1008 | 107 | 15 | CID000000813 |
| Disease | developmental and epileptic encephalopathy 87 (implicated_via_orthology) | 1.25e-05 | 2 | 105 | 2 | DOID:0112221 (implicated_via_orthology) | |
| Disease | prostate adenocarcinoma (is_implicated_in) | 4.78e-05 | 20 | 105 | 3 | DOID:2526 (is_implicated_in) | |
| Disease | disease of metabolism (implicated_via_orthology) | 5.56e-05 | 21 | 105 | 3 | DOID:0014667 (implicated_via_orthology) | |
| Disease | prostate cancer (is_implicated_in) | 6.33e-05 | 117 | 105 | 5 | DOID:10283 (is_implicated_in) | |
| Disease | Cerebrovascular accident | 7.21e-05 | 62 | 105 | 4 | C0038454 | |
| Disease | dermatitis (is_implicated_in) | 1.86e-04 | 6 | 105 | 2 | DOID:2723 (is_implicated_in) | |
| Disease | epilepsy (implicated_via_orthology) | 2.99e-04 | 163 | 105 | 5 | DOID:1826 (implicated_via_orthology) | |
| Disease | Nephronophthisis | 4.44e-04 | 9 | 105 | 2 | cv:C0687120 | |
| Disease | Tonic-Clonic Epilepsy | 5.54e-04 | 10 | 105 | 2 | C0014549 | |
| Disease | Cryptogenic Tonic-Clonic Epilepsy | 5.54e-04 | 10 | 105 | 2 | C0751117 | |
| Disease | Epilepsy, Tonic-Clonic, Symptomatic | 5.54e-04 | 10 | 105 | 2 | C0751119 | |
| Disease | Epilepsy, Tonic-Clonic, Familial | 5.54e-04 | 10 | 105 | 2 | C0751118 | |
| Disease | Jeune thoracic dystrophy | 6.76e-04 | 11 | 105 | 2 | C0265275 | |
| Disease | early infantile epileptic encephalopathy (implicated_via_orthology) | 6.76e-04 | 11 | 105 | 2 | DOID:0050709 (implicated_via_orthology) | |
| Disease | Short Rib-Polydactyly Syndrome | 9.54e-04 | 13 | 105 | 2 | C0036996 | |
| Disease | Migraine Disorders | 9.54e-04 | 13 | 105 | 2 | C0149931 | |
| Disease | obesity (implicated_via_orthology) | 1.05e-03 | 215 | 105 | 5 | DOID:9970 (implicated_via_orthology) | |
| Disease | Saldino-Noonan Syndrome | 1.11e-03 | 14 | 105 | 2 | C0036069 | |
| Disease | Majewski Syndrome | 1.11e-03 | 14 | 105 | 2 | C0024507 | |
| Disease | inositol measurement | 1.11e-03 | 14 | 105 | 2 | EFO_0010504 | |
| Disease | hypertension (biomarker_via_orthology) | 1.33e-03 | 227 | 105 | 5 | DOID:10763 (biomarker_via_orthology) | |
| Disease | Dementia | 1.65e-03 | 17 | 105 | 2 | C0497327 | |
| Disease | Multiple congenital anomalies | 1.65e-03 | 17 | 105 | 2 | C0000772 | |
| Disease | breast carcinoma (is_marker_for) | 1.70e-03 | 66 | 105 | 3 | DOID:3459 (is_marker_for) | |
| Disease | Oral Submucous Fibrosis | 1.85e-03 | 18 | 105 | 2 | C0029172 | |
| Disease | colorectal cancer (is_marker_for) | 2.43e-03 | 157 | 105 | 4 | DOID:9256 (is_marker_for) | |
| Disease | Disease Exacerbation | 2.91e-03 | 165 | 105 | 4 | C0235874 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EIVGDVRGKGLMIGI | 426 | Q9BYV1 | |
| QRLGGGPSDAKEVME | 391 | P31751 | |
| PGSEVLKVVAMDGDR | 261 | Q96JP9 | |
| GEGPERGRVKIADMG | 161 | Q9BWU1 | |
| DAEGDIGKAEVMPVR | 1721 | Q68DQ2 | |
| EGGTVVYGGKVMDRP | 391 | P49419 | |
| DVVIVERGKGDGVPE | 536 | Q13111 | |
| AVVPEMEKRGGGSVV | 151 | Q9BTZ2 | |
| IMKGGAVAADGRIEP | 281 | Q92997 | |
| KVEVDELGMGFRPGD | 301 | Q7L311 | |
| LIVVGVGKPAEMRSG | 2651 | Q6ZS30 | |
| EMCREEGGEGTPVKQ | 1821 | Q9Y4B5 | |
| GIGLVEEPMDKVEEG | 176 | Q8NG50 | |
| AVVPEMEKRGGGSVV | 151 | Q6PKH6 | |
| KRREMDDGLAEGGPQ | 76 | Q96GY3 | |
| AREVLDVAAGMIKPG | 146 | P53582 | |
| VPGLGEMGKEETLTR | 16 | Q9BY89 | |
| MDQEPVGGVERGEAV | 1 | Q8N128 | |
| GGGPKRLGRDVEMEE | 96 | Q68CZ1 | |
| PMGRKQGGTLDDLEE | 551 | O14920 | |
| MLKPGGQVDGDEALE | 2181 | Q14643 | |
| MGGAVVDEGPTGVKA | 1 | O15427 | |
| GIIRGMDMGAKVPDE | 536 | Q07954 | |
| EKEMLDGGVPGTTVR | 36 | Q5T1J6 | |
| RLVAMAAVGEPEKAG | 1001 | Q8WVS4 | |
| DGVLKPEGGGMLSEE | 1246 | Q86VH2 | |
| GGDVDVRELLPGSVM | 166 | P80217 | |
| GKEIIGGMLDIEPRL | 846 | Q2TBE0 | |
| RLKVEEPGMGAEEAV | 1731 | Q9UM47 | |
| EEVGQGMPLVSEGDR | 1561 | P48681 | |
| MVARGDLGIEIPAEK | 291 | P14618 | |
| DGIMVARGDLGIEIP | 331 | P30613 | |
| GRGMEFKLIEPEEVA | 391 | P41161 | |
| SVREETGMGDIPDVK | 346 | Q6NSJ5 | |
| EDEIPVVAIMATGGG | 291 | P0C869 | |
| PGDLVVREGSVGRKM | 451 | Q9P1Z3 | |
| KGPELMAIEGLENGE | 641 | Q8WXE0 | |
| PEGAIMGDVKVEDGA | 191 | Q86WI3 | |
| DVIGLERGGGKTEVM | 566 | Q9UG01 | |
| GGDVELPRELAKMIE | 96 | Q8WVH0 | |
| MLAGRLKPDEGGEVP | 391 | P61221 | |
| GDGVGPELMHAVKEV | 56 | O43837 | |
| GVGEPVELDKGVRAM | 881 | Q8N9C0 | |
| IAGKILEMDDPRAVG | 276 | O00341 | |
| MKAGRVVVADPQAGG | 1551 | Q8N1P7 | |
| VKVLEEDPMVGGVGG | 226 | Q92819 | |
| KVPEKMVVIGAGVIG | 211 | P09622 | |
| FPMELGIRVGLGKED | 26 | Q8N7U6 | |
| MVGVGGGDVEDVTPR | 1 | P09038 | |
| GKRQGGQMVDDVELP | 466 | Q92636 | |
| LDVMGALRKEGEPGS | 36 | Q13683 | |
| KGERRMEDEGGFPVP | 976 | Q6ZRV2 | |
| QRDPGETVGGDEIVM | 136 | P31944 | |
| GEGPERGRVKIADMG | 161 | P49336 | |
| GVEDGQTVRMPVGKR | 311 | Q96EY1 | |
| MEKLGVEPEEEGGGD | 1 | Q9UNA4 | |
| GGRLGEAEGLMKVEA | 411 | Q9HBR0 | |
| EGLLMPVVKSEGGED | 566 | P28340 | |
| VGGPMDASVEEEGVR | 36 | P01034 | |
| ELMIPGGAKVIDATG | 41 | Q9BPU6 | |
| GKMPIDLVIEDRDGG | 66 | A6NDR6 | |
| VEPVGMLKEGDRVEI | 256 | P43121 | |
| EQIKRGGDAGMPGIE | 241 | Q6P4E1 | |
| VGVGPKGEESMAARV | 251 | Q9GZR2 | |
| VTPVKAGRLVVEMGG | 151 | Q9NX20 | |
| GFGMDEALKDPVGRE | 331 | P49802 | |
| MEKEGVLTREDRPGG | 96 | A6NNA2 | |
| RDGLEVVVTPGAMGA | 611 | O95754 | |
| EGEGQGPLIRVDMTI | 761 | Q8N3T6 | |
| EPEEELQKGMGTVEG | 1416 | Q13428 | |
| GAGSEVEVDMFLRKP | 846 | Q5VVP1 | |
| GIRGPEDVAKMGITE | 101 | P41252 | |
| LVVALGPGGVSMDEK | 251 | O15260 | |
| GTPVKIGEGMLADFV | 341 | Q9H0H5 | |
| IPRAESGGKGERMAD | 101 | Q7L0J3 | |
| DTPGVKMIVVLGEIG | 706 | P53396 | |
| MEGGGGIPLETLKEE | 1 | Q6P4H8 | |
| AGITGMAERIPELGE | 306 | O95573 | |
| EEEMAVVPQGLFRGG | 306 | P10645 | |
| GMAEEAERPGEKAGQ | 291 | Q9H4L4 | |
| AEPEMDVRKRTGVAG | 131 | Q9NZ43 | |
| ELGGTIGDIEGMPFV | 146 | Q9NRF8 | |
| VAALRKMVAEEGGVP | 306 | Q70EL4 | |
| KMVAEEGGVPADEVI | 311 | Q70EL4 | |
| AGEIGEMKDGVPEGA | 261 | P16989 | |
| EIPIEGLEFMGHGKE | 56 | O43715 | |
| TLKPGDRIVEVDGMD | 1201 | O75970 | |
| REEEKVSGVVGDPQM | 621 | P15923 | |
| GGMRAVEFKVVETDP | 156 | P55072 | |
| RDIEGMGVPEIKYGD | 336 | Q15413 | |
| MDRISNGGLEEGKPV | 161 | Q9GZZ9 | |
| MGKGERVEGPEVAAG | 876 | Q9BXM0 | |
| GMEVVKVGGPVYRIG | 446 | O15067 | |
| MAGPRVEVDGSIMEG | 1 | O00442 | |
| MLPQVGKDGVLRDGD | 1351 | O94964 | |
| GKVHGEEEMIPGSVL | 156 | Q92800 | |
| TGDAGGREPMEEKLL | 656 | Q9UKN8 | |
| EMDGFKPNEGVIIIG | 466 | Q96TA2 | |
| GEVVEGDPDKVLRML | 406 | O43615 | |
| AGDGPLVIMGEVRDG | 496 | Q96NZ8 | |
| GGKIQIEMETVPEAG | 101 | Q9UK13 | |
| EEDEEKGGRRIMGPR | 496 | Q9NPG3 | |
| EGPGTGGREMVEEAI | 256 | Q9H7P9 | |
| KGVPGVKAERFEEGM | 461 | Q9NV66 | |
| KGIPVGGERMEPEEE | 46 | Q9Y6X0 | |
| MDGIVPDIAVGTKRG | 1 | P26599 | |
| GRKMAAGDIGELLVP | 16 | Q92995 | |
| MEPGRGGTETVGKFE | 1 | O75385 | |
| GKFSGIRMEGEEALP | 366 | Q15911 | |
| GGSPVIEGVDDAKEM | 291 | Q9Y4I1 |